Biofilm, 10-HOME and Breast Implant Symptoms: What the Research Found

In this brief presentation, Dr. Robert Whitfield summarizes a Journal of Clinical Investigation study involving 178 participants divided into three groups: 86 individuals with symptoms attributed to breast implant illness (BII), 55 individuals with breast implants but no symptoms, and 37 individuals without implants. The study reported that the symptomatic BII group exhibited greater biofilm abundance, higher levels of the molecule oxaliplatin‑tenheim (10‑HOME), and a higher prevalence of Staphylococcus epidermidis in tissue samples compared with the control groups. Dr. Whitfield emphasizes that these findings are associative, not proof of causation, and invites viewers to a live explanation of the evidence on Thursday, August 27 at 6 p.m. Central across multiple social platforms, followed by a private, free Q&A session on his Dr. Rob Circle platform.










